2 Stocks That Could Double Your Money in 2021
Both of these businesses prospered even during a volatile year -- and the coming months could be even more impressive.
Fulgent Genetics, Inc.
FLGT
FLGT
$70.72
$1.65
2.4%
Price as of January 15, 2021, 9:00 p.m. EST
View Interactive FLGT Charts
Fulgent Genetics is a technology company that provides comprehensive diagnostic genetic testing using its proprietary platform, which integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools, and integrated laboratory processes.
Interactive Chart
News & Analysis: Fulgent Genetics, Inc.
These Were the 5 Best Diagnostics Stocks of 2020
These winners are positioned for gains even after COVID.
Why Fulgent Genetics Stock Is Dropping Today
A Wall Street analyst downgraded the genetics testing provider.
Stock Markets Sink, but These 2020 Stock Winners Look Good for the New Year
Both of these stocks are up more than 300% in 2020 and have room to run.
Fulgent Genetics Stock: Buy at the High?
Could this genetic testing provider turn its coronavirus bump into long-term share price growth?
Is Fulgent Genetics Stock a Buy?
Should you invest in shares of this high-flying coronavirus stock before it's too late?
How Did Fulgent Genetics Stock Perform in 2020?
The encore to a great 2019: Even more gains this year.
Why Fulgent Genetics Stock Surged 38% in November
The COVID-19 pandemic continues to provide a tailwind for the genetic testing specialist.
This Small-Cap Stock Will Be a Long-Term Winner From the Pandemic
Wall Street seems worried that the arrival of coronavirus vaccines will take the wind out of the sails of this genetic and medical testing company. That view misses the big picture.
Why Fulgent Genetics Stock Is Soaring 11.2% Today
Coronavirus testing demand caused revenue and profit to surge last quarter.
